Aquestive Therapeutics, Inc. (AQST)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$3.59
-4.52%
Mkt Cap $461.72M
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$9.00
Range $6.00 – $12.00
Implied Upside
+150.7%
Consensus $9.00 vs current $3.59